Company / Accounts Receivable
AtriCure, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$66.7M
FY2025
5-year range
$33.0M / $66.7M
FY2021-FY2025
Trend
+10.5%
vs FY2024
Sector context
#113 of 143
Health Care
What the data says
AtriCure, Inc.'s accounts receivable of $67M is lower than 79% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 5 consecutive years, from $23M in FY2020 to $67M in FY2025.
Based on SEC 10-K filings.
$67M in FY2025 with a 5-year CAGR of +23.6%.
Improved from $53M to $67M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +23.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 143This company $66.7M Sector average $1.3B
▼
-95.0% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +23.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 10.5% year-over-year.
- Ranks #113 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.7M | +10.5% |
| FY2024 | $60.3M | +14.9% |
| FY2023 | $52.5M | +23.0% |
| FY2022 | $42.7M | +29.3% |
| FY2021 | $33.0M | +42.7% |
| FY2020 | $23.1M | -17.5% |
| FY2019 | $28.0M | +11.3% |
| FY2018 | $25.2M | +9.1% |
| FY2017 | $23.1M | +9.4% |
| FY2016 | $21.1M | +8.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026